These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1248113)

  • 21. Fractionation of tritiated digoxin and dihydrodigoxin with DEAE-sephadex LH-20.
    Sugden D; Ahmed M; Gault MH
    J Chromatogr; 1976 Jun; 121(2):401-4. PubMed ID: 932155
    [No Abstract]   [Full Text] [Related]  

  • 22. Digoxin biotransformation.
    Gault MH; Longerich LL; Loo JC; Ko PT; Fine A; Vasdev SC; Dawe MA
    Clin Pharmacol Ther; 1984 Jan; 35(1):74-82. PubMed ID: 6690172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous analysis of digitoxin and its clinically relevant metabolites using high-performance liquid chromatography and radioimmunoassay.
    Santos SR; Kirch W; Ohnhaus EE
    J Chromatogr; 1987 Aug; 419():155-64. PubMed ID: 3667774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporin and quinidine inhibition of renal digoxin excretion: evidence for luminal secretion of digoxin.
    De Lannoy IA; Koren G; Klein J; Charuk J; Silverman M
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F613-22. PubMed ID: 1357987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatographic characterization of endogenous digoxin-like immunoreactive substances present in serum and urine of infants using gel filtration with Sephadex G 25.
    Clerico A; Boldrini A; Balzan S; Biver P; Fantoni M
    Biol Neonate; 1985; 47(4):217-22. PubMed ID: 3995104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digoxin-like immunoreactivity in cord blood plasma extracts is not only due to endogenous corticosteroids.
    Yiannakou L; Loucari-Yiannakou E; Souvatzoglou A
    Clin Biochem; 1991 Dec; 24(6):475-82. PubMed ID: 1773487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex difference in the biliary excretion of digoxin and its metabolites in aging Wistar rats.
    Kitani K; Ohta M; Kanai S; Sato Y
    Arch Gerontol Geriatr; 1985 Apr; 4(1):1-12. PubMed ID: 4004407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary excretion of reduced metabolites of digoxin.
    Lindenbaum J; Tse-Eng D; Butler VP; Rund DG
    Am J Med; 1981 Jul; 71(1):67-74. PubMed ID: 7246583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of spironolactone on excretion of 3H-digoxin and its metabolites in rats.
    Wirth KE; Frölich JC
    Eur J Pharmacol; 1974 Nov; 29(1):43-51. PubMed ID: 4435043
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of digoxin dosage on the digoxin-quinidine interaction in the bile duct-cannulated rat.
    Hewick DS; Ostenfeld T
    J Pharm Pharmacol; 1987 Jan; 39(1):64-7. PubMed ID: 2880991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative studies on renal and biliary excretion of digoxin and beta-methyldigoxin in man].
    Köthe E; Kramer P; Scheler F
    Verh Dtsch Ges Inn Med; 1973; 79():1042-4. PubMed ID: 4790090
    [No Abstract]   [Full Text] [Related]  

  • 32. Interindividual differences in the pharmacokinetics of digitoxin and digoxin during long-term treatment.
    Haustein KO
    Eur J Clin Pharmacol; 1981 Jan; 19(1):45-51. PubMed ID: 7461023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of intravenous furosemide on the renal excretion of digoxin.
    McAllister RG; Howell SM; Gomer MS; Selby JB
    J Clin Pharmacol; 1976; 16(2-3):110-7. PubMed ID: 943423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digoxin metabolism in patients.
    Peters U; Falk LC; Kalman SM
    Arch Intern Med; 1978 Jul; 138(7):1074-6. PubMed ID: 666466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of furosemide on the renal excretion of digoxin.
    Brown DD; Dormois JC; Abraham GN; Lewis K; Dixon K
    Clin Pharmacol Ther; 1976 Oct; 20(4):395-400. PubMed ID: 975715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The question of cumulation of digoxin metabolites in renal failure.
    Gibson TP; Nelson HA
    Clin Pharmacol Ther; 1980 Feb; 27(2):219-23. PubMed ID: 7353343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of beta-methyldigoxin in healthy humans II: Oral studies and bioavailability.
    Hinderling PH; Garrett ER; Wester RC
    J Pharm Sci; 1977 Mar; 66(3):314-25. PubMed ID: 845795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Separation of prostaglandin metabolites on sephadex LH 20 columns.
    Hansen HS; Bukhave K
    Prostaglandins; 1978 Aug; 16(2):311-8. PubMed ID: 704935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of furosemide on serum clearance and renal excretion of digoxin.
    Tsutsumi E; Fujiki H; Takeda H; Fukushima H
    J Clin Pharmacol; 1979 Apr; 19(4):200-4. PubMed ID: 438354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.